Navigation Links
Bolli Becomes New Editor-In-Chief of Circulation Research

PHILADELPHIA, July 29 /PRNewswire/ -- Roberto Bolli, M.D., is the new editor-in-chief of Circulation Research: Journal of the American Heart Association.

Bolli, chief of the Division of Cardiovascular Medicine and director of the Institute of Molecular Cardiology at the University of Louisville in Kentucky, will assume his role with the July 31 issue of the journal, posted online on July 30.

"It is an honor and a privilege to serve as editor-in-chief of this prestigious and critically important scientific journal," Bolli said. "In an era of incredibly rapid progress in cardiovascular medicine, the scientific discoveries leading to the next generation of clinical advances will appear first in the pages of Circulation Research."

Circulation Research, the official bi-weekly journal of the American Heart Association's Council on Basic Cardiovascular Sciences, is devoted to new basic science research from all disciplines related to cardiac and vascular biology and cardiovascular disease. The journal presents the most significant research from fields including cellular biology, molecular biology and molecular genetics, as well as biochemistry, biophysics, pathology, physiology and pharmacology.

Each issue of Circulation Research features reports on molecular medicine, cellular biology and integrative physiology. Respected investigators and clinicians present editorials and authoritative reviews on topics of special interest, providing readers with indispensable perspectives on new and emerging scientific concepts.

"We are on the threshold of amazing new discoveries in areas such as regenerative cardiology, embryonic development of the heart and blood vessels and the genetics of cardiovascular disease," Bolli said. "My associate editors and I are eager to meet the challenge of guiding the journal through the next phase in its evolution."

The July 31 issue of Circulation Research will include a cover redesign as part of numerous upcoming changes. The journal is published by Lippincott Williams & Wilkins, a division of Wolters Kluwer Health.

The journal's Web site,, has also been redesigned and streamlined, facilitating browsing and quick access to featured articles and "Online First" papers. Subscribers and readers have access to the journal's expanded online archive, including the complete history of the journal from the 1950s to the present.

With an impact factor of 9.989, Circulation Research is ranked No. 3 among 78 journals in cardiac and cardiovascular systems, No. 2 among 56 journals in peripheral vascular disease and No. 3 among 62 journals in hematology, according to the 2008 ISI Journal Citation Reports(R), published by Thomson Scientific.

"The breathtaking pace of new discoveries in the basic science of cardiology makes the appointment of a new editor of Circulation Research a noteworthy event," said Donna Arnett, Ph.D., chairperson of the American Heart Association's Scientific Publishing Committee. "We recognize the service and achievement of Dr. Eduardo Marban, outgoing editor-in-chief, and we are certain that Dr. Bolli and his team will continue to build on the journal's long history of scientific excellence."

About the American Heart Association

Founded in 1924, the American Heart Association is the nation's oldest and largest voluntary health organization dedicated to building healthier lives, free of heart disease and stroke. These diseases, America's No. 1 and No. 3 killers, and all other cardiovascular diseases claim over 870,000 lives a year. In fiscal year 2006-07 the association invested more than $554 million in research, professional and public education, advocacy and community service programs to help all Americans live longer, healthier lives. To learn more, call 1-800-AHA-USA1 or visit

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services. LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry.

Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of 3.4 billion euro ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit for information about our market positions, customers, brands, and organization.

NR09-1088 (Circ Res/Bolli)

SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Crdentia Promotes Kevin Bollin to Area Manager of Austin, Dallas and San Antonio, Texas, Markets
2. MRI finds breast cancer before it becomes dangerous
3. MinuteClinic Becomes Participating Provider with Assurant Health
4. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
5. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
6. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
7. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
8. Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of College of Optometrists in Vision Development (COVD); Unveils 7-Part Development Plan for Ongoing Growth
9. PharmMD Becomes an ASCP MTM Provider Partner
10. Outcomes Pharmaceutical Health Care(r) Becomes an ASCP MTM Provider Partner
11. Pharm MD Solutions Becomes an ASCP MTM Provider Partner
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... for mental health and wellness consultation, has collaborated with Women’s Web – ... their reader’s queries on topics on mental and emotional well-being relationship, life ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published November ... more widely heralded as a breakthrough for performing hernia repairs. The article explains that ... surgery is that it can greatly reduce the pain that a patient might otherwise ...
(Date:11/25/2015)... Raton, Florida (PRWEB) , ... November 25, 2015 ... ... diagnostic testing for physicians and athletic programs, launches new Wimbledon Athletics ... importance of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
Breaking Medicine Technology: